Taken together, these findings suggest GLP-1 RAs could broaden the therapeutic toolkit for HS, particularly for patients with concomitant obesity, and potentially even for those without, via anti-inflammatory effects
Overall, current data do not suggest a major increase in serious adverse events with dual therapy
Its used to stimulate insulin secretion and can affect appetite
We do over a million treatments a year, more than anyone, says CEO Clint Weiler, who joined as CFO in 2020 and stepped into the top role when the founders retired
Unlike traditional compounds that target a single receptor, Retatrutide is recognized as a triple hormone receptor agonist, meaning it interacts with three distinct pathways involved in metabolic activity